Life sciences · Journal article
Quality in Sport · August 14, 2026
Reinforces what was already believed, rather than introducing something new.
This narrative literature review synthesizes evidence that obesity promotes chronic systemic inflammation ('metaflammation') that accelerates periodontal tissue destruction through shared immuno-metabolic pathways, including dysregulation of adipokines, oxidative stress, and epigenetic reprogramming. The data confirm that obesity increases periodontitis risk substantially (31–35%) and that weight loss can restore response to conventional periodontal therapy, but the review does not present primary trial data or establish new clinical standards.
Narrative literature review. Humans with obesity and/or periodontitis; pediatric oral health outcomes also included.. Intervention: Weight loss and metabolic interventions combined with oral therapy (SRP); reviewed evidence of non-surgical periodontal therapy.. Compared with: Non-surgical periodontal therapy (SRP) alone under unmanaged metabolic stress..
Obesity increases periodontitis risk by 31–35% (OR 1.31–1.35) Obesity disrupts leptin/adiponectin and RANKL/OPG axis, accelerating alveolar bone loss Visceral adiposity impairs responses to non-surgical periodontal therapy (scaling and root planing; SRP)
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
Clinicians should recognize that obesity is a significant risk factor for periodontitis (31–35% increased risk) and that conventional non-surgical periodontal therapy alone may be insufficient without concurrent metabolic intervention and weight management. Interdisciplinary care combining oral therapy with metabolic stabilization is recommended for long-term periodontal stability in obese patients.
A narrative literature synthesis confirming established mechanistic and epidemiological links between obesity and periodontitis, without new primary data or practice-changing clinical trials.
As stated by the source record.
Quoted from the source exactly as published.
Clinicians should recognize that obesity is a significant risk factor for periodontitis (31–35% increased risk) and that conventional non-surgical periodontal therapy alone may be insufficient without concurrent metabolic intervention and weight management. Interdisciplinary care combining oral therapy with metabolic stabilization is recommended for long-term periodontal stability in obese patients.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Background: Obesity promotes "metaflammation" – a chronic, low-grade systemic inflammatory state closely tied to periodontitis. This pathological synergy accelerates the destruction of tooth-supporting tissues through shared immuno-metabolic pathways. Aim: The aim of this study is to synthesize current scientific evidence regarding the systemic effects of obesity on periodontal health, focusing on the molecular, microbiological, and clinical mechanisms that link these two chronic conditions. Materials and Methods: A comprehensive review of databases, including PubMed, Scopus, and Quality in Sport, was conducted to identify systematic reviews and clinical trials. The investigation concentrated on adipokine profiles, clinical parameters (CAL, PD, BOP), and the influence of metabolic interventions on periodontal outcomes. Results Obesity accelerates alveolar bone loss by disrupting leptin/adiponectin and the RANKL/OPG axis. Systemic oxidative stress (elevated ROS, MDA) and endotoxemia (LPS/TLR-4) worsen local inflammation, which is sustained by HDAC1-mediated epigenetic memory. Clinically, obesity increases periodontitis risk by 31–35% (OR 1.31–1.35) and degrades pediatric oral health (DMFT, OHRQoL). Visceral adiposity impairs responses to non-surgical periodontal therapy (SRP), but weight loss restores healing and clinical attachment gain. Conclusions Adipose tissue dysfunction drives periodontal breakdown by reprogramming host immune and epigenetic landscapes. Mechanical debridement (SRP) often fails alone under unmanaged metabolic stress. Long-term stability requires interdisciplinary care combining oral therapy with metabolic stabilization and weight management.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.